Trial site
Sarah Cannon Research Institute
- 18running trials
- 6closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Conditions
- Lung cancer12 trials
- Colorectal cancer5 trials
- Gastric and oesophageal cancer5 trials
- Head and neck cancer5 trials
- Liver and biliary tract cancer4 trials
- Ovarian cancer4 trials
- Pancreatic cancer4 trials
- Triple-negative breast cancer4 trials
- Bladder cancer3 trials
- Cervical cancer3 trials
- Childhood cancers2 trials
- Melanoma2 trials
- and 14 more
- Phase
- Phase 210 trials
- Phase 15 trials
- Phase 35 trials
- Phase 1/24 trials
- Status
- Recruiting14 trials
- Completed4 trials
- Active, not recruiting3 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Lead sponsor
- BioNTech SE5 trials
- Hoffmann-La Roche4 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
- AVEO Pharmaceuticals, Inc.1 trial
- Fore Biotherapeutics1 trial
- and 11 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Recruiting
Recruiting
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Recruiting
Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Active, not recruiting
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer7 recruiting
- Head and neck cancer5 recruiting
- Colorectal cancer4 recruiting
- Gastric and oesophageal cancer4 recruiting
- Bladder cancer3 recruiting
- Ovarian cancer3 recruiting
- Triple-negative breast cancer3 recruiting
- Cervical cancer2 recruiting
- Childhood cancers2 recruiting
- Liver and biliary tract cancer2 recruiting
- Pancreatic cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Melanoma1 recruiting
- Mesothelioma1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Prostate cancer1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Terminated
Completed
Terminated
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026